Browsing by Author "ca2284b3-6e54-4268-8adf-7b8c2434e46b"

Now showing items 1-5 of 5

    • Blocking of p38 and Transforming Growth Factor 
      Gárate, David; Rojas Colonelli, Nicole; Peña, Corina; Salazar, Lorena; Abello Cáceres, Paula; Pesce Reyes, Bárbara; Aravena, Octavio; García González, Paulina; Ribeiro, Carolina Hager; Molina Sampayo, María Carmen; Catalán Martina, Diego; Aguillón Gutiérrez, Juan Carlos (American College of Rheumatology, 2013)
      Objective. Dendritic cells (DCs) modulated with lipopolysaccharide (LPS) are able to reduce inflammation when therapeutically administered into mice with collagen-induced arthritis (CIA). The aim of this study was to ...
    • Decreased invariant natural killer T-cell-mediated antitumor immune response in patients with gastric cancer 
      Ascui, Gabriel; Gálvez Jirón, Felipe; Kramm, Karina; Schafer, Carolina; Siña, Josefina; Pola, Víctor; Cristi, Francisca; Hernández, Carolina; Garrido Tapia, Macarena; Pesce Reyes, Bárbara; Bustamante Zamorano, Marco; Fluxá Rojas, Paula; Molina Sampayo, María Carmen; Ribeiro, Carolina H. (Wiley, 2020)
      Gastric cancer (GC) is the third most common cause of cancer-related death worldwide. Invariant natural killer T (iNKT) cells are innate-like cytotoxic T lymphocytes involved in tumor immune surveillance. They can be ...
    • Dexamethasone and monophosphoryl lipid a induce a distinctive profile on monocyte-derived dendritic cells ... 
      García González, Paulina; Schinnerling, Katina; Sepúlveda Gutierrez, Alejandro; Maggi, Jaxaira; Mehdi, Ahmed M.; Nel, Hendrik J.; Pesce Reyes, Bárbara; Larrondo Lillo, Milton; Aravena, Octavio; Molina Sampayo, María Carmen; Catalán Martina, Diego; Thomas, Ranjeny; Verdugo Salgado, Ricardo; Aguillón Gutiérrez, Juan Carlos (Frontiers Media SA, 2017)
      There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target for immunotherapy. However, the molecular bases that drive the differentiation of monocyte-derived DCs (moDCs) toward a ...
    • STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by ... 
      Garrido Tapia, Macarena; Hernández González, Carolina; Ascui, Gabriel; Kramm, Karina; Morales Huber, Claudia; Garatea, Valentina; Zúniga, Roberto; Bustamante Zamorano, Marco; Aguillón Gutiérrez, Juan Carlos; Catalán Martina, Diego; Ribeiro, Carolina Hager; Molina Sampayo, María Carmen (Elsevier, 2017)
      NKG2D is an activating receptor expressed on NK cells that binds to a variety of ligands, including MICA and MICB. These cell surface glycoproteins are overexpressed under cellular transformation, thus playing an important ...
    • Treatment with dexamethasone and monophosphoryl lipid a removes disease-associated transcriptional signatures ... 
      García González, Paulina; Schinnerling, Katina; Sepúlveda Gutiérrez, Alejandro; Maggi, Jaxaira; Hoyos, Lorena; Morales, Rodrigo; Mehdi, Ahmed; Nel, Hendrik; Soto Sáez, Lilian; Pesce Reyes, Bárbara; Molina Sampayo, María Carmen; Cuchacovich Turteltaub, Miguel; Larrondo Lillo, Milton; Neira, Oscar; Catalán Martina, Diego; Hilkens, Catharien M.; Thomas, Ranjeny; Verdugo Salgado, Ricardo; Aguillón Gutiérrez, Juan Carlos (Frontiers Media, 2016-10-25)
      Tolerogenic dendritic cells (TolDCs) are promising tools for therapy of autoimmune diseases, such as rheumatoid arthritis (RA). Here, we characterize monocyte-derived TolDCs from RA patients modulated with dexamethasone ...